Panacea Life Sciences Holdings Inc · OTC:PLSH
Panacea Life Sciences — Investor Presentation (July 2023)
23 slides from Panacea Life Sciences's investor presentation, Jul 10, 2023
Slide 1: PLSH Investor Presentation
panacealife.com | OTCQB: PLSH Panacea Life Sciences Exhibit 99.3 July 2023 PLSH Investor Presentation
Slide 2: Disclaimer
Ppanacealife.com | OTCQB: PLSH — Disclaimer ‘This Presentation (the “Presentation”) has been prepared solely for informational purposes by Company and any individuals mentioned in the Presentation (together, “Company") and is being furnished solely for use by prospective investors and other third pa
Slide 3: Panacea Life Sciences Overview
panacealife.com | OTCQB: PLSH — Panacea Life Sciences Overview “ Panacea Life Sciences Holdings, Inc. (PLSH) is a holding company structured to support the natural ingredients and health & wellness industry. Its subsidiary, Panacea Life Sciences, Inc. (PLS), is dedicated to manufacturing, product de
Slide 4: Proven Leadership Team
—— Proven Leadership Team LESLIE BUTTORFF LARRY WERT Chief Executive Officer & Chairman (Over 35 years as a senior executive in management, ‘marketing, engineering, and financial analyses at companies such as AT Kearny, Arthur D. Little, EDS (HP) and Perot Systems. 8S Statistics and Masters in Indus
Slide 5: About PLSH
ABOUT PLSH - PANACEA LIFE SCIENCES HOLDINGS, INC. is a holding company that currently operates several divisions with plans to expand operations 7|NITRO TIKAVA CONTRACT MANUFACTURING FOR NUTRACEUTICAL & CANNABINOID PLANT-BASED RETAIL PRODUCT SKUS COMPANIES ANT BASED ALT- )UCTS MUSHROOM/PSILOCYBIN, K
Slide 6: I. Contract Manufacturing
I. CONTRACT MANUFACTURING Panacea has significant manufacturing capabilities and its primary focus in contract manufacturing for the nutraceutical, cannabinoid, mushroom and kratom industries. Consumers are actively searching for pharmaceutical alternatives with medical benefits $320 billion market
Slide 7: State-of-the-Art 51,000 sq.ft. cGMP Manufacturing Facility
State-of-the-Art 51,000 sq.ft. cGMP Manufacturing Facility Producing High Quality, Pharmaceutical Grade Products $1.28 Total capacity of 500k-1M— Oval 7.5 Bovine production capabilities softgel production per shift 150k — 300k ~ Oval 7.5 VEGAN 10,000 — Liquid fils per day softgel production per shif
Slide 8: GMP Certified (21 CFR Part 111)
GMP Certified (21 CFR Part i iii, SGS Good Manufacturing Practice een eies ote pnaat naneoatonng tant —saaerieees aucun me gt meine erate eore Ppanacealife.com | OTCQB: PLSH nese AN es) Pie SSnces ‘The US. Food and rug Adminstration (FDA hereby prowdng you wth aconematon copy ofthe Information FDA r
Slide 9: R&D | Custom Formulation
R&D | Custom Formulation Panacea‘s Focus on Efficacy, Bioavailability Panacea’s R&D department has spent years researching and testing various blends of ingredients that were very difficult to encapsulate. Our highly trained chemists and technicians have the opportunity to take risks, think outside-
Slide 10: Vegan Softgel Production
Vegan Softgel Production We spent several years of development to become experts in this field. (Cassava Root es Ppanacealife.com | OTCQB: PLSH Why tapioca starch softgels? S 100% No genetic Easily vegan-friendly modification digestible Excellent thermal stability Helps with gastrointestinal issues
Slide 11: Bovine Softgel Production
Ppanacealife.com | OTCQB: PLSH Bovine Softgel Production Panacea’s Bovine Softgel Production Includes: Two softgel machines that can produce over 1.5m softgels per day Multiple die capabilities to meet customers’ gel size needs Experienced staff who are GMP-trained R&D, formulation and stability stu
Slide 12: In-House Analytics & Quality
In-House Analytics & Quality Panacea's Focus on Science, Research & Quality One of our strongest company attributes is our well-equipped, state-of the- art, chemical analytical laboratory at the Panacea Life Sciences Cannabinoid Research Center at Colorado State University. Highly trained chemists a
Slide 13: II. CBD/Nutraceutical Retail Strategy
II. SRR/ERETRACEMTICAL RETAIL STRATEGY Panacea seeks to acquire other brands in both the CBD and natural plant-based categories to increase revenue and market share in a difficult but still growing market. ~64 Million people have tried CBD in the last 24 months oO 7 Billion market valued in 2021 $20
Slide 14: Current Product SKUs and White Label Opportunities
Current Product SKUs and White Label Opportunities “PANA Health-Related Skin Care Products = Topicals t Patches and K-Tape Dogs, Cats and Horses Gummies Ready to expand your product line? Panacea can manufacture additional lines of products in our laboratory in Golden, Colo. or through select manufa
Slide 15: Growing Popularity of Kratom and Kava
CERTAINLY, THE GROWING POPULARITY OF KRATOM AND KAVAAS A MOOD- BOOSTER, SOCIAL DRINK. ANTI-ANXIETY REMEDY, HEALTH SUPPLEMENT OR ALTERNATIVE TO ALCOHOL IS A POSITIVE DEVELOPMENT. as most numbers of kava bars
Slide 16: IV. Distribution Strategy
IV. DISTRIBUTION STRATGEY PANACEA DISTRIBUTION operates a cash and carry warehouse for the smoke and vape industry/Delta products/Kratom products. It also includes our proprietary Al vending machine--VICKI iS Market size value in 202 INMIL 2 24,172 21,064 catiak? 2019 2020 20x 2022 2023
Slide 17: V. Alt-Natural Products
V. ALT-NATURAL PRODUCTS + Mushroom/Fungi Products * Functional (Lion's Mane) * Recreational (Amanita) * Psychedelics (Psilocybin) + Kratom + Beverages * Softgels + Powders + Alt-Cannabinoids + THCV THCA CBN CBG
Slide 18: N7 Lizard Juice Natural Energy Drinks
Unlike most other energy beverages, N7 Lizard Juice natural energy drinks don’t contain ingredients such as artificial sweeteners or synthetic colorings, which some people prefer to leave out of their diets. They're made with naturally derived ingredients like green tea, yerba mate, and botanical ex
Slide 19: About the Energy Drink Industry
ABOUT THE ENERGY DRINK INDUSTRY ‘An energy drink is a non-alcohol beverage that contains stimulant components, such as caffeine, sugar, other sweeteners, herbal extracts, taurine, and amino acids. Over the last 20 years, energy drinks such as Red Bull and Monster have become increasingly popular, ra
Slide 20: Advancements Through Scientific Expertise
— Advancements Through Scientific Expertise Panacea Scientific Advisory Board Nathan Morris, MD General Practitioner Highly regarded holistic doctor and actual customer of Panacea Janice Knox, MD General Practitioner Leading expert in Cannabis/Hemp Industry Paul Dean, MD Dermatologist Strategic Part
Slide 21: On-Going Research Studies for Pharmaceutical Alternatives
—On-Going Research Studies for Pharmaceutical Altern Near-Term Opportunities to Provide Solutions in Areas of High-Value and Unmet Need Method Development: Removal of pesticides, isolation of CBDV, CBC Animal Studies Human Clinical Studies McGrath and Moreno (CSU): CBD and Reynolds (CSU) Crews (ASU)
Slide 22: PLSH Proposal for Acquisition Companies
panacealife.com | OTCQB: PLSH — PLSH Proposal for Acquisition Companies PLSH is currently traded on OTCQB and is in good standing. Market cap before the Cannabis market turndown was $75.6M. It currently has one subsidiary, Panacea Life Sciences, Inc. Currently 15M shares outstanding and price is aro
Slide 23: Contact: Leslie Buttorff
panacealife.com | OTCQB: PLSH Panacea Life Sciences Contact: Leslie Buttorff |Founder & CEO leslie.buttorff@panacealife.com
Panacea Life Sciences Holdings — Investor Presentation (July 2023) on 6ix